Noetik Collaborates with Memorial Sloan Kettering Cancer Center to Advance AI Models for Cancer Biology
Noetik, an AI company focused on oncology, has announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to advance the next generation of cancer biology world models. This partnership combines MSK's extensive oncology expertise and research resources with Noetik's AI and data foundry capabilities. The goal is to create a more diverse and comprehensive understanding of cancer development and ultimately improve clinical outcomes. Noetik will gain access to unique and proprietary multimodal spatial oncology datasets from MSK, spanning tens of thousands of patients, anchored by MSK's Clinicogenomic Harmonized Oncologic Real-World Dataset (CHORD). These resources will be used to enrich Noetik's foundation models, known as OCTO, for both pre-training and post-training, enhancing therapeutic response prediction and enabling novel target discovery.